Palmisano Robert J - Aug 14, 2023 Form 4 Insider Report for AEON Biopharma, Inc. (AEON)

Role
Director, 10%+ Owner
Signature
/s/ Alexander Wilson, Attorney-in-Fact
Stock symbol
AEON
Transactions as of
Aug 14, 2023
Transactions value $
$0
Form type
4
Date filed
8/16/2023, 04:06 PM
Previous filing
Jun 5, 2023
Next filing
Mar 21, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AEON Stock Option Award $0 +58.9K $0.00 58.9K Aug 14, 2023 Common Stock 58.9K $5.47 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents an award of stock options on August 14, 2023, which vests in three yearly installments from August 14, 2023, subject to the reporting person's continued service through the applicable vesting date.